(+)-catechin multiple interactions ISO RGD:1604061 6480464 [Oxygen deficiency co-treated with Catechin] results in increased expression of CCL5 mRNA CTD PMID:35883890 (-)-alpha-phellandrene increases expression ISO RGD:1604061 6480464 alpha phellandrene results in increased expression of CCL5 mRNA CTD PMID:25075043 (-)-anisomycin decreases expression ISO RGD:1604061 6480464 Anisomycin results in decreased expression of CCL5 protein CTD PMID:20116850 (-)-demecolcine increases expression ISO RGD:1604061 6480464 Demecolcine results in increased expression of CCL5 mRNA CTD PMID:23649840 (4-oxo-3-\{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl\}-3,4-dihydrophthalazin-1-yl)acetic acid multiple interactions ISO RGD:69127 6480464 zopolrestat inhibits the reaction [Antigens, Plant results in increased expression of CCL5 mRNA] CTD PMID:21334316 (R)-noradrenaline increases secretion ISO RGD:1604061 6480464 Norepinephrine results in increased secretion of CCL5 protein CTD PMID:16782692 (R)-noradrenaline multiple interactions ISO RGD:1604061 6480464 Prazosin inhibits the reaction [Norepinephrine results in increased secretion of CCL5 protein] CTD PMID:16782692 (S)-nicotine increases expression ISO RGD:1604061 6480464 Nicotine results in increased expression of CCL5 mRNA CTD PMID:18247414 1,4-benzoquinone increases expression ISO RGD:1604061 6480464 quinone results in increased expression of CCL5 protein CTD PMID:17572062 1,4-phenylenediamine increases expression ISO RGD:1604061 6480464 4-phenylenediamine results in increased expression of CCL5 mRNA CTD PMID:27585668 1-chloro-2,4-dinitrobenzene multiple interactions ISO RGD:69127 6480464 diflorasone inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL5 protein] CTD PMID:15491423 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:69127 6480464 Dinitrochlorobenzene results in decreased expression of CCL5 mRNA CTD PMID:21404309 , PMID:28219650 1-chloro-2,4-dinitrobenzene increases secretion ISO RGD:1604061 6480464 Dinitrochlorobenzene results in increased secretion of CCL5 protein CTD PMID:20488241 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:69127 6480464 Dinitrochlorobenzene results in increased expression of CCL5 protein CTD PMID:15491423 1-fluoro-2,4-dinitrobenzene increases expression ISO RGD:69127 6480464 Dinitrofluorobenzene results in increased expression of CCL5 mRNA, Dinitrofluorobenzene results in increased expression of CCL5 protein CTD PMID:15719370 1-naphthyl isothiocyanate affects expression EXP 6480464 1-Naphthylisothiocyanate affects the expression of CCL5 protein CTD PMID:25051504 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CCL5 mRNA CTD PMID:30723492 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CCL5 mRNA CTD PMID:25380136 1-nitropyrene increases expression ISO RGD:1604061 6480464 1-nitropyrene results in increased expression of CCL5 mRNA CTD PMID:19879285 14-Deoxy-11,12-didehydroandrographolide multiple interactions ISO RGD:1604061 6480464 14-deoxy-11, 12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] CTD PMID:27089844 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:1604061 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] CTD PMID:23688403 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CCL5 protein CTD PMID:25051504 17alpha-ethynylestradiol increases expression ISO RGD:69127 6480464 Ethinyl Estradiol results in increased expression of CCL5 mRNA CTD PMID:15885639 17alpha-ethynylestradiol decreases expression ISO RGD:69127 6480464 Ethinyl Estradiol results in decreased expression of CCL5 mRNA CTD PMID:12538720 17beta-estradiol multiple interactions ISO RGD:1604061 6480464 [Estradiol co-treated with norethindrone acetate] results in decreased expression of CCL5 protein, [Progesterone co-treated with Estradiol] results in decreased expression of CCL5 mRNA CTD PMID:16842799 , PMID:17404688 17beta-estradiol decreases expression ISO RGD:69127 6480464 Estradiol results in decreased expression of CCL5 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL5 mRNA more ... CTD PMID:21277368 , PMID:32741896 17beta-estradiol increases expression ISO RGD:1604061 6480464 Estradiol results in increased expression of CCL5 mRNA CTD PMID:21185374 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL5 mRNA CTD PMID:32741896 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:69127 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1604061 6480464 Tetrachlorodibenzodioxin promotes the reaction [[AHR protein binds to CCL5 enhancer] which results in increased expression of CCL5 mRNA] more ... CTD PMID:12200463 , PMID:14761676 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CCL5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69127 6480464 Tetrachlorodibenzodioxin results in increased expression of CCL5 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CCL5 mRNA CTD PMID:22808131 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CCL5 mRNA CTD PMID:20059583 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:69127 6480464 Tetrachlorodibenzodioxin affects the expression of CCL5 mRNA CTD PMID:21570461 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:69127 6480464 Tetrachlorodibenzodioxin results in decreased expression of CCL5 mRNA CTD PMID:18684927 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69127 6480464 [Tetrachlorodibenzodioxin co-treated with TNF protein] affects the expression of CCL5 mRNA more ... CTD PMID:20819909 , PMID:21979172 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1604061 6480464 Tetrachlorodibenzodioxin results in increased expression of CCL5 mRNA CTD PMID:12200463 2,6-di-tert-butyl-4-methylphenol decreases expression ISO RGD:69127 6480464 Butylated Hydroxytoluene results in decreased expression of CCL5 mRNA CTD PMID:19925653 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO RGD:69127 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL5 mRNA more ... CTD PMID:21146893 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:1604061 6480464 Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL5 protein] CTD PMID:18080321 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CCL5 mRNA] CTD PMID:17109745 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one multiple interactions ISO RGD:1604061 6480464 Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] CTD PMID:23688403 2-naphthylamine increases expression ISO RGD:1604061 6480464 2-Naphthylamine results in increased expression of CCL5 mRNA CTD PMID:18247414 2-tert-butylhydroquinone increases secretion ISO RGD:1604061 6480464 2-tert-butylhydroquinone results in increased secretion of CCL5 protein CTD PMID:30806763 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:34256052 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:1604061 6480464 4-OH-2' more ... CTD PMID:14761676 3,3',5-triiodo-L-thyronine increases expression ISO RGD:1604061 6480464 Triiodothyronine results in increased expression of CCL5 mRNA CTD PMID:14761676 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of CCL5 mRNA CTD PMID:23358152 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of CCL5 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69127 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA CTD PMID:23503329 3-methylcholanthrene decreases expression ISO RGD:69127 6480464 Methylcholanthrene results in decreased expression of CCL5 mRNA CTD PMID:20713471 3-phenylprop-2-enal increases secretion ISO RGD:1604061 6480464 cinnamaldehyde results in increased secretion of CCL5 protein CTD PMID:20488241 3-phenylprop-2-enal decreases expression ISO RGD:69127 6480464 cinnamaldehyde results in decreased expression of CCL5 mRNA CTD PMID:28219650 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of CCL5 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CCL5 mRNA CTD PMID:25380136 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:69127 6480464 Oxazolone results in decreased expression of CCL5 mRNA CTD PMID:21404309 4-hydroxynon-2-enal decreases expression ISO RGD:69127 6480464 4-hydroxy-2-nonenal results in decreased expression of CCL5 mRNA CTD PMID:19191707 4-hydroxynon-2-enal multiple interactions ISO RGD:69127 6480464 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA], 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] CTD PMID:19627980 4-nitroquinoline N-oxide increases expression ISO RGD:69127 6480464 4-Nitroquinoline-1-oxide results in increased expression of CCL5 mRNA CTD PMID:22561872 4-nitroquinoline N-oxide decreases expression ISO RGD:69127 6480464 4-Nitroquinoline-1-oxide results in decreased expression of CCL5 mRNA CTD PMID:22561872 7,12-dimethyltetraphene multiple interactions ISO RGD:1604061 6480464 9 more ... CTD PMID:12200463 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:19480007 7-ketocholesterol multiple interactions ISO RGD:1604061 6480464 resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CCL5 protein] CTD PMID:24895526 7-ketocholesterol increases expression ISO RGD:1604061 6480464 7-ketocholesterol results in increased expression of CCL5 protein CTD PMID:24895526 8-Br-cAMP multiple interactions ISO RGD:69127 6480464 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA], 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] CTD PMID:10495789 8-chloro-2'-deoxyguanosine decreases expression ISO RGD:69127 6480464 8-chloro-2'-deoxyguanosine results in decreased expression of CCL5 mRNA CTD PMID:31066272 9,10-anthraquinone increases expression ISO RGD:1604061 6480464 9, 10-anthraquinone results in increased expression of CCL5 mRNA CTD PMID:23333790 9-hydroxycanthin-6-one decreases expression ISO RGD:1604061 6480464 9-hydroxycanthin-6-one results in decreased expression of CCL5 mRNA CTD PMID:29225138 acetamide increases expression EXP 6480464 acetamide results in increased expression of CCL5 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:69127 6480464 CD8A protein promotes the reaction [Acrolein results in increased expression of CCL5 mRNA] CTD PMID:17950725 acrolein increases expression ISO RGD:69127 6480464 Acrolein results in increased expression of CCL5 mRNA CTD PMID:17950725 adenine increases expression ISO RGD:69127 6480464 Adenine results in increased expression of CCL5 mRNA CTD PMID:34619300 albuterol multiple interactions ISO RGD:1604061 6480464 [Beclomethasone co-treated with Albuterol] results in decreased secretion of CCL5 protein CTD PMID:15679717 aldehydo-D-glucosamine multiple interactions ISO RGD:1604061 6480464 Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL5 protein] CTD PMID:18080321 aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CCL5 mRNA] CTD PMID:17109745 aldehydo-D-glucose increases expression ISO RGD:69127 6480464 Glucose results in increased expression of CCL5 mRNA CTD PMID:17178593 aldehydo-D-glucose decreases expression ISO RGD:1604061 6480464 Glucose results in decreased expression of CCL5 mRNA CTD PMID:32942007 aldehydo-D-glucose increases expression ISO RGD:1604061 6480464 Glucose results in increased expression of CCL5 mRNA CTD PMID:31655124 aldehydo-D-glucose multiple interactions ISO RGD:1604061 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA CTD PMID:32613381 alexidine decreases expression ISO RGD:1604061 6480464 alexidine results in decreased expression of CCL5 protein CTD PMID:20116850 all-trans-retinoic acid decreases expression ISO RGD:1604061 6480464 Tretinoin results in decreased expression of CCL5 protein CTD PMID:17118196 all-trans-retinoic acid increases expression ISO RGD:1604061 6480464 Tretinoin results in increased expression of CCL5 mRNA CTD PMID:15498508 alpha-phellandrene increases expression ISO RGD:1604061 6480464 alpha phellandrene results in increased expression of CCL5 mRNA CTD PMID:25075043 aluminium hydroxide increases secretion ISO RGD:1604061 6480464 Aluminum Hydroxide results in increased secretion of CCL5 protein CTD PMID:18390722 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CCL5 mRNA CTD PMID:16483693 amorolfine multiple interactions ISO RGD:1604061 6480464 amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] CTD PMID:23688403 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:69127 6480464 pyrazolanthrone inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA], pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA] CTD PMID:23958496 antimycin A decreases expression ISO RGD:1604061 6480464 Antimycin A results in decreased expression of CCL5 protein CTD PMID:20116850 antirheumatic drug decreases expression ISO RGD:1604061 6480464 Antirheumatic Agents results in decreased expression of CCL5 mRNA CTD PMID:24449571 apocynin multiple interactions ISO RGD:1604061 6480464 acetovanillone inhibits the reaction [TNF protein results in increased expression of CCL5 protein] CTD PMID:22414048 apocynin multiple interactions ISO RGD:69127 6480464 acetovanillone inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] CTD PMID:10495789 arecoline increases secretion ISO RGD:1604061 6480464 Arecoline results in increased secretion of CCL5 protein CTD PMID:21297082 aripiprazole multiple interactions ISO RGD:1604061 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of CCL5 mRNA CTD PMID:31476115 aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CCL5 mRNA CTD PMID:23912714 Aroclor 1254 increases expression ISO RGD:69127 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CCL5 mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:1604061 6480464 Arsenic affects the methylation of CCL5 gene CTD PMID:25304211 arsane multiple interactions ISO RGD:69127 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL5 protein CTD PMID:35777461 arsenic atom affects methylation ISO RGD:1604061 6480464 Arsenic affects the methylation of CCL5 gene CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:69127 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL5 protein CTD PMID:35777461 arsenite(3-) affects expression ISO RGD:1604061 6480464 arsenite affects the expression of CCL5 mRNA CTD PMID:22959463 asbestos increases expression ISO RGD:1604061 6480464 Asbestos results in increased expression of CCL5 protein CTD PMID:25162674 atropine multiple interactions ISO RGD:69127 6480464 [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 mRNA], [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein] CTD PMID:22245128 Bardoxolone methyl multiple interactions ISO RGD:69127 6480464 bardoxolone methyl inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CCL5 protein] CTD PMID:26918785 beclomethasone decreases expression ISO RGD:1604061 6480464 Beclomethasone results in decreased expression of CCL5 mRNA, Beclomethasone results in decreased expression of CCL5 protein CTD PMID:8534483 beclomethasone multiple interactions ISO RGD:1604061 6480464 [Beclomethasone co-treated with Albuterol] results in decreased secretion of CCL5 protein more ... CTD PMID:10903220 more ... benazepril multiple interactions EXP 6480464 benazepril inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] CTD PMID:16284884 benzalkonium chloride increases expression ISO RGD:69127 6480464 Benzalkonium Compounds results in increased expression of CCL5 protein CTD PMID:30517752 benzene increases expression ISO RGD:1604061 6480464 Benzene results in increased expression of CCL5 mRNA, Benzene results in increased expression of CCL5 protein CTD PMID:11306435 , PMID:33064461 benzene-1,2,4-triol affects expression ISO RGD:1604061 6480464 hydroxyhydroquinone affects the expression of CCL5 protein CTD PMID:17572062 benzethonium chloride decreases expression ISO RGD:1604061 6480464 Benzethonium results in decreased expression of CCL5 protein CTD PMID:20116850 benzo[a]pyrene increases expression ISO RGD:1604061 6480464 Benzo(a)pyrene results in increased expression of CCL5 mRNA, Benzo(a)pyrene results in increased expression of CCL5 protein CTD PMID:11306435 , PMID:18247414 benzo[a]pyrene increases methylation ISO RGD:1604061 6480464 Benzo(a)pyrene results in increased methylation of CCL5 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1604061 6480464 Benzo(a)pyrene affects the methylation of CCL5 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:69127 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA CTD PMID:27858113 benzo[a]pyrene decreases expression ISO RGD:69127 6480464 Benzo(a)pyrene results in decreased expression of CCL5 mRNA CTD PMID:20713471 more ... benzo[a]pyrene increases expression ISO RGD:69127 6480464 Benzo(a)pyrene results in increased expression of CCL5 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CCL5 mRNA CTD PMID:21839799 benzo[a]pyrene multiple interactions ISO RGD:1604061 6480464 Benzo(a)pyrene promotes the reaction [AHR protein results in increased expression of CCL5 protein] CTD PMID:12200463 benzo[b]fluoranthene decreases expression ISO RGD:69127 6480464 benzo(b)fluoranthene results in decreased expression of CCL5 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:69127 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA CTD PMID:27858113 Benzo[k]fluoranthene decreases expression ISO RGD:69127 6480464 benzo(k)fluoranthene results in decreased expression of CCL5 mRNA CTD PMID:26377693 beryllium sulfate increases expression ISO RGD:1604061 6480464 beryllium sulfate results in increased expression of CCL5 mRNA CTD PMID:16314022 beta-D-glucosamine multiple interactions ISO RGD:1604061 6480464 Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL5 protein] CTD PMID:18080321 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CCL5 mRNA] CTD PMID:17109745 beta-Funaltrexamine multiple interactions ISO RGD:1604061 6480464 beta-funaltrexamine inhibits the reaction [Morphine results in decreased expression of CCL5 protein] CTD PMID:11106302 beta-naphthoflavone decreases expression ISO RGD:1604061 6480464 beta-Naphthoflavone results in decreased expression of CCL5 mRNA CTD PMID:32858204 bezafibrate multiple interactions ISO RGD:1604061 6480464 Bezafibrate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of CCL5 mRNA] more ... CTD PMID:12126966 , PMID:12586603 bis(2-chloroethyl) sulfide increases expression ISO RGD:1604061 6480464 Mustard Gas results in increased expression of CCL5 protein CTD PMID:17620002 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CCL5 mRNA CTD PMID:24988533 bisphenol A affects expression ISO RGD:69127 6480464 bisphenol A affects the expression of CCL5 mRNA CTD PMID:35341816 bisphenol A increases expression ISO RGD:69127 6480464 bisphenol A results in increased expression of CCL5 mRNA CTD PMID:34281243 bisphenol A multiple interactions ISO RGD:69127 6480464 [bisphenol A affects the susceptibility to Ovalbumin] which results in increased expression of and results in increased secretion of CCL5 protein CTD PMID:29737898 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CCL5 gene CTD PMID:28505145 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CCL5 mRNA CTD PMID:25181051 bleomycin A2 increases expression ISO RGD:69127 6480464 Bleomycin results in increased expression of CCL5 mRNA CTD PMID:32828905 bleomycin A2 multiple interactions ISO RGD:69127 6480464 SLCO2A1 gene mutant form promotes the reaction [Bleomycin results in increased expression of CCL5 mRNA] CTD PMID:32828905 budesonide multiple interactions ISO RGD:1604061 6480464 Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 mRNA], Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] CTD PMID:10903220 , PMID:14643170 butanal increases expression ISO RGD:1604061 6480464 butyraldehyde results in increased expression of CCL5 mRNA CTD PMID:26079696 butenafine multiple interactions ISO RGD:1604061 6480464 butenafine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] CTD PMID:23688403 cadmium atom multiple interactions ISO RGD:69127 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CCL5 mRNA CTD PMID:31904401 cadmium atom multiple interactions ISO RGD:1604061 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCL5 mRNA CTD PMID:35301059 cadmium dichloride increases secretion ISO RGD:1604061 6480464 Cadmium Chloride results in increased secretion of CCL5 protein CTD PMID:26138014 cadmium dichloride multiple interactions ISO RGD:69127 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CCL5 mRNA CTD PMID:31904401 cadmium dichloride multiple interactions ISO RGD:1604061 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCL5 mRNA, Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of CCL5 protein] CTD PMID:26138014 , PMID:35301059 Calcimycin multiple interactions ISO RGD:1604061 6480464 CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species], IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]] CTD PMID:12797483 Calcimycin multiple interactions EXP 6480464 [Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4 more ... CTD PMID:18083043 calcium atom increases uptake ISO RGD:1604061 6480464 CCL5 protein results in increased uptake of Calcium CTD PMID:10984371 calcium(0) increases uptake ISO RGD:1604061 6480464 CCL5 protein results in increased uptake of Calcium CTD PMID:10984371 camptothecin decreases expression ISO RGD:1604061 6480464 Camptothecin results in decreased expression of CCL5 protein CTD PMID:20116850 cannabidiol multiple interactions ISO RGD:1604061 6480464 Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] CTD PMID:31250491 carbon nanotube affects expression ISO RGD:69127 6480464 Nanotubes, Carbon affects the expression of CCL5 mRNA CTD PMID:23845593 carbon nanotube increases secretion ISO RGD:1604061 6480464 Nanotubes, Carbon results in increased secretion of CCL5 protein CTD PMID:29348435 carbon nanotube multiple interactions ISO RGD:1604061 6480464 1-palmitoyl-2-arachidonyl-3-phosphorylcholine metabolite inhibits the reaction [Nanotubes more ... CTD PMID:29348435 carbon nanotube decreases expression ISO RGD:69127 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carrageenan increases expression ISO RGD:69127 6480464 Carrageenan results in increased expression of CCL5 protein CTD PMID:12444156 carrageenan multiple interactions EXP 6480464 isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein], Quercetin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] CTD PMID:14654164 catechol increases expression ISO RGD:1604061 6480464 catechol results in increased expression of CCL5 protein CTD PMID:17572062 celecoxib decreases expression ISO RGD:69127 6480464 Celecoxib results in decreased expression of CCL5 mRNA CTD PMID:12902868 cephaeline decreases expression ISO RGD:1604061 6480464 cephaelin results in decreased expression of CCL5 protein CTD PMID:20116850 cerium trichloride increases expression ISO RGD:1604061 6480464 cerous chloride results in increased expression of CCL5 mRNA CTD PMID:28954213 cerium trichloride multiple interactions ISO RGD:1604061 6480464 [cerous chloride co-treated with lanthanum chloride] results in increased expression of CCL5 mRNA CTD PMID:28954213 chenodeoxycholic acid multiple interactions ISO RGD:1604061 6480464 Bezafibrate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of CCL5 mRNA] more ... CTD PMID:12126966 chenodeoxycholic acid increases expression ISO RGD:69127 6480464 Chenodeoxycholic Acid results in increased expression of CCL5 mRNA CTD PMID:21224055 chenodeoxycholic acid increases expression ISO RGD:1604061 6480464 Chenodeoxycholic Acid results in increased expression of CCL5 mRNA, Chenodeoxycholic Acid results in increased expression of CCL5 protein CTD PMID:12126966 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:30744511 chloroprene decreases expression ISO RGD:69127 6480464 Chloroprene results in decreased expression of CCL5 mRNA CTD PMID:23125180 chloroquine multiple interactions ISO RGD:69127 6480464 Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL5 protein] CTD PMID:22341560 choline multiple interactions ISO RGD:69127 6480464 [PANX1 gene mutant form affects the susceptibility to [Dietary Fats co-treated with Choline deficiency]] which results in decreased expression of CCL5 protein CTD PMID:29246445 chromium(6+) affects expression ISO RGD:69127 6480464 chromium hexavalent ion affects the expression of CCL5 mRNA CTD PMID:28472532 chrysene multiple interactions ISO RGD:69127 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA CTD PMID:27858113 ciglitazone multiple interactions ISO RGD:69127 6480464 ciglitazone inhibits the reaction [Thioglycolates results in increased secretion of CCL5 protein] CTD PMID:12624547 cisplatin affects expression EXP 6480464 Cisplatin affects the expression of CCL5 protein CTD PMID:25051504 cisplatin increases expression ISO RGD:69127 6480464 Cisplatin results in increased expression of CCL5 mRNA, Cisplatin results in increased expression of CCL5 protein CTD PMID:15814532 more ... cisplatin multiple interactions ISO RGD:69127 6480464 [Cisplatin co-treated with TNF protein] results in increased expression of CCL5 mRNA more ... CTD PMID:15814532 more ... clopidogrel increases expression ISO RGD:1604061 6480464 clopidogrel results in increased expression of CCL5 mRNA CTD PMID:16856976 cobalt atom multiple interactions ISO RGD:69127 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA CTD PMID:23503329 codeine multiple interactions ISO RGD:1604061 6480464 Codeine affects the secretion of and affects the expression of CCL5 protein CTD PMID:17441793 colforsin daropate hydrochloride multiple interactions ISO RGD:69127 6480464 Colforsin inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA], Colforsin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] CTD PMID:10495789 copper atom multiple interactions ISO RGD:1604061 6480464 [Copper co-treated with Hydrogen Peroxide] promotes the reaction [CCL5 protein binds to CCL5 protein] more ... CTD PMID:21963154 , PMID:24690739 copper atom increases secretion ISO RGD:69127 6480464 Copper results in increased secretion of CCL5 protein CTD PMID:19635393 copper(0) multiple interactions ISO RGD:1604061 6480464 [Copper co-treated with Hydrogen Peroxide] promotes the reaction [CCL5 protein binds to CCL5 protein] more ... CTD PMID:21963154 , PMID:24690739 copper(0) increases secretion ISO RGD:69127 6480464 Copper results in increased secretion of CCL5 protein CTD PMID:19635393 crocidolite asbestos decreases expression ISO RGD:1604061 6480464 Asbestos, Crocidolite results in decreased expression of CCL5 mRNA CTD PMID:29523930 crocidolite asbestos increases expression ISO RGD:69127 6480464 Asbestos more ... CTD PMID:29507420 cycloheximide increases expression ISO RGD:1604061 6480464 Cycloheximide results in increased expression of CCL5 mRNA CTD PMID:21146893 cycloheximide multiple interactions ISO RGD:1604061 6480464 Cycloheximide inhibits the reaction [TNF protein results in increased expression of CCL5 protein] more ... CTD PMID:21146893 , PMID:22121136 cyclosporin A affects expression EXP 6480464 Cyclosporine affects the expression of CCL5 protein CTD PMID:25051504 cyclosporin A multiple interactions ISO RGD:69127 6480464 7-oxozeanol inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA] more ... CTD PMID:23958496 , PMID:27585667 cyclosporin A increases expression ISO RGD:69127 6480464 Cyclosporine results in increased expression of CCL5 mRNA, Cyclosporine results in increased expression of CCL5 protein CTD PMID:19770486 more ... cyfluthrin multiple interactions ISO RGD:1604061 6480464 Melatonin inhibits the reaction [cyfluthrin results in increased expression of CCL5 mRNA] CTD PMID:31330490 cyfluthrin increases expression ISO RGD:1604061 6480464 cyfluthrin results in increased expression of CCL5 mRNA CTD PMID:31330490 cytidine multiple interactions ISO RGD:69127 6480464 [Chlorine binds to Cytidine] which results in decreased expression of CCL5 mRNA CTD PMID:31066272 D-glucose increases expression ISO RGD:69127 6480464 Glucose results in increased expression of CCL5 mRNA CTD PMID:17178593 D-glucose increases expression ISO RGD:1604061 6480464 Glucose results in increased expression of CCL5 mRNA CTD PMID:31655124 D-glucose decreases expression ISO RGD:1604061 6480464 Glucose results in decreased expression of CCL5 mRNA CTD PMID:32942007 D-glucose multiple interactions ISO RGD:1604061 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA CTD PMID:32613381 D-penicillamine increases expression EXP 6480464 Penicillamine results in increased expression of CCL5 mRNA CTD PMID:19575532 dantrolene affects expression EXP 6480464 Dantrolene affects the expression of CCL5 protein CTD PMID:25051504 decabromodiphenyl ether affects expression ISO RGD:69127 6480464 decabromobiphenyl ether affects the expression of CCL5 protein CTD PMID:21791381 deguelin multiple interactions ISO RGD:1604061 6480464 deguelin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] CTD PMID:28529457 deoxycholic acid increases expression ISO RGD:69127 6480464 Deoxycholic Acid results in increased expression of CCL5 mRNA CTD PMID:21224055 deoxynivalenol increases expression ISO RGD:69127 6480464 deoxynivalenol results in increased expression of CCL5 mRNA CTD PMID:22968694 , PMID:35925383 deoxynivalenol multiple interactions ISO RGD:69127 6480464 benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of CCL5 mRNA] CTD PMID:35925383 deoxynivalenol increases expression ISO RGD:1604061 6480464 deoxynivalenol results in increased expression of CCL5 mRNA CTD PMID:27757495 dequalinium decreases expression ISO RGD:1604061 6480464 Dequalinium results in decreased expression of CCL5 protein CTD PMID:20116850 desipramine multiple interactions ISO RGD:1604061 6480464 Desipramine inhibits the reaction [TNF protein results in increased expression of CCL5 protein] CTD PMID:17477857 dexamethasone multiple interactions ISO RGD:1604061 6480464 Dexamethasone inhibits the reaction [[Toluene 2 more ... CTD PMID:16908450 , PMID:27568862 dexamethasone increases expression ISO RGD:69127 6480464 Dexamethasone results in increased expression of CCL5 mRNA CTD PMID:21041162 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4], Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] CTD PMID:18083043 dexamethasone multiple interactions ISO RGD:69127 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA more ... CTD PMID:10495789 more ... dichlorine increases expression ISO RGD:69127 6480464 Chlorine results in increased expression of CCL5 protein CTD PMID:23146759 dichlorine multiple interactions ISO RGD:69127 6480464 [Chlorine binds to Cytidine] which results in decreased expression of CCL5 mRNA CTD PMID:31066272 dichloromethane decreases expression EXP 6480464 Methylene Chloride results in decreased expression of CCL5 mRNA CTD PMID:20955722 Didecyldimethylammonium increases expression ISO RGD:69127 6480464 didecyldimethylammonium results in increased expression of CCL5 protein CTD PMID:19762220 diethylstilbestrol increases expression ISO RGD:69127 6480464 Diethylstilbestrol results in increased expression of CCL5 mRNA CTD PMID:21041162 diflorasone multiple interactions ISO RGD:69127 6480464 diflorasone inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL5 protein] more ... CTD PMID:15491423 digitoxigenin decreases expression ISO RGD:1604061 6480464 Digitoxigenin results in decreased expression of CCL5 protein CTD PMID:20116850 digoxin decreases expression ISO RGD:1604061 6480464 Digoxin results in decreased expression of CCL5 protein CTD PMID:20116850 dimethyl sulfoxide multiple interactions ISO RGD:1604061 6480464 Dimethyl Sulfoxide inhibits the reaction [[Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased secretion of CCL5 protein] CTD PMID:21878375 dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium decreases expression ISO RGD:1604061 6480464 Benzethonium results in decreased expression of CCL5 protein CTD PMID:20116850 dinitrogen multiple interactions ISO RGD:1604061 6480464 [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of CCL5 protein CTD PMID:30711708 dioxygen multiple interactions ISO RGD:1604061 6480464 [Oxygen deficiency co-treated with Catechin] results in increased expression of CCL5 mRNA, Oxygen affects the reaction [AHR protein results in increased expression of CCL5 mRNA] CTD PMID:27103661 , PMID:35883890 dioxygen multiple interactions ISO RGD:69127 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL5 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:1604061 6480464 Oxygen results in increased expression of CCL5 mRNA CTD PMID:27103661 disulfiram multiple interactions ISO RGD:69127 6480464 Disulfiram inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide] more ... CTD PMID:19016906 disulfiram multiple interactions ISO RGD:1604061 6480464 [Disulfiram binds to Copper] which results in increased expression of CCL5 mRNA CTD PMID:24690739 doxorubicin decreases expression ISO RGD:1604061 6480464 Doxorubicin results in decreased expression of CCL5 mRNA CTD PMID:29803840 emetine decreases expression ISO RGD:1604061 6480464 Emetine results in decreased expression of CCL5 protein CTD PMID:20116850 endosulfan increases expression ISO RGD:1604061 6480464 Endosulfan results in increased expression of CCL5 mRNA CTD PMID:28108160 enilconazole increases expression ISO RGD:1604061 6480464 enilconazole results in increased expression of CCL5 mRNA CTD PMID:32201337 Erionite increases expression ISO RGD:69127 6480464 erionite results in increased expression of CCL5 protein CTD PMID:29279043 ethambutol affects expression EXP 6480464 Ethambutol affects the expression of CCL5 protein CTD PMID:25051504 ethanol increases secretion ISO RGD:1604061 6480464 Ethanol results in increased secretion of CCL5 protein CTD PMID:28763032 ethionamide affects expression EXP 6480464 Ethionamide affects the expression of CCL5 protein CTD PMID:25051504 ethyl acetate increases expression ISO RGD:1604061 6480464 ethyl acetate results in increased expression of CCL5 protein CTD PMID:11306435 Ethyl icosapentate multiple interactions ISO RGD:69127 6480464 [eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of CCL5 mRNA CTD PMID:23665937 ethylbenzene decreases expression EXP 6480464 ethylbenzene results in decreased expression of CCL5 mRNA CTD PMID:20955722 ethylene glycol increases expression EXP 6480464 Ethylene Glycol results in increased expression of CCL5 protein CTD PMID:16284884 ethylene glycol multiple interactions EXP 6480464 benazepril inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] more ... CTD PMID:16284884 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:1604061 6480464 Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased secretion of CCL5 protein] CTD PMID:21245013 fenofibrate multiple interactions ISO RGD:1604061 6480464 Fenofibrate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of CCL5 mRNA] more ... CTD PMID:12126966 , PMID:12586603 Fexofenadine hydrochloride multiple interactions ISO RGD:1604061 6480464 fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] more ... CTD PMID:15460210 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of CCL5 mRNA CTD PMID:18035473 flunisolide multiple interactions ISO RGD:1604061 6480464 flunisolide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] CTD PMID:10903220 fluoxetine multiple interactions ISO RGD:1604061 6480464 Fluoxetine inhibits the reaction [TNF protein results in increased expression of CCL5 protein] CTD PMID:17477857 flutamide affects expression EXP 6480464 Flutamide affects the expression of CCL5 protein CTD PMID:25051504 fluticasone multiple interactions ISO RGD:1604061 6480464 Fluticasone inhibits the reaction [TNF protein results in increased expression of CCL5 protein] more ... CTD PMID:10903220 more ... folic acid increases expression ISO RGD:1604061 6480464 Folic Acid results in increased expression of CCL5 mRNA CTD PMID:28752528 folic acid increases expression ISO RGD:69127 6480464 Folic Acid results in increased expression of CCL5 mRNA CTD PMID:25629700 , PMID:34619300 formaldehyde multiple interactions ISO RGD:69127 6480464 Formaldehyde promotes the reaction [Antigens, Dermatophagoides results in increased expression of CCL5 protein] CTD PMID:12435080 formaldehyde decreases expression ISO RGD:1604061 6480464 Formaldehyde results in decreased expression of CCL5 mRNA CTD PMID:28937961 formaldehyde increases expression ISO RGD:1604061 6480464 Formaldehyde results in increased expression of CCL5 mRNA CTD PMID:23649840 formoterol fumarate multiple interactions ISO RGD:1604061 6480464 [Beclomethasone co-treated with Formoterol Fumarate] results in decreased secretion of CCL5 protein CTD PMID:15679717 fragrance increases expression ISO RGD:1604061 6480464 Perfume results in increased expression of CCL5 mRNA CTD PMID:24768652 fucoidan decreases expression ISO RGD:1604061 6480464 fucoidan results in decreased expression of CCL5 protein CTD PMID:16201850 fulvestrant increases expression ISO RGD:1604061 6480464 fulvestrant results in increased expression of CCL5 mRNA CTD PMID:12154049 fumonisin B1 increases expression ISO RGD:1604061 6480464 fumonisin B1 results in increased expression of CCL5 mRNA CTD PMID:27757495 gemfibrozil decreases expression EXP 6480464 Gemfibrozil results in decreased expression of CCL5 protein CTD PMID:25051504 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CCL5 mRNA CTD PMID:22061828 , PMID:33387578 glucose increases expression ISO RGD:69127 6480464 Glucose results in increased expression of CCL5 mRNA CTD PMID:17178593 glucose increases expression ISO RGD:1604061 6480464 Glucose results in increased expression of CCL5 mRNA CTD PMID:31655124 glucose decreases expression ISO RGD:1604061 6480464 Glucose results in decreased expression of CCL5 mRNA CTD PMID:32942007 glucose multiple interactions ISO RGD:1604061 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA CTD PMID:32613381 glutathione multiple interactions ISO RGD:1604061 6480464 Glutathione inhibits the reaction [[Particulate Matter analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL5 protein] more ... CTD PMID:10919993 glycine betaine increases expression EXP 6480464 Betaine results in increased expression of CCL5 mRNA CTD PMID:26391144 gold atom multiple interactions ISO RGD:69127 6480464 [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein CTD PMID:22155353 gold atom increases secretion ISO RGD:69127 6480464 Gold results in increased secretion of CCL5 protein CTD PMID:22155353 gold(0) multiple interactions ISO RGD:69127 6480464 [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein CTD PMID:22155353 gold(0) increases secretion ISO RGD:69127 6480464 Gold results in increased secretion of CCL5 protein CTD PMID:22155353 graphene oxide increases expression ISO RGD:69127 6480464 graphene oxide analog results in increased expression of CCL5 mRNA CTD PMID:33227293 GW 1929 decreases response to substance ISO RGD:1604061 6480464 GW 1929 results in decreased susceptibility to CCL5 protein CTD PMID:18158351 helenalin multiple interactions ISO RGD:1604061 6480464 helenalin inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] CTD PMID:23688403 heparan sulfate multiple interactions ISO RGD:1604061 6480464 Heparitin Sulfate inhibits the reaction [Hydrogen Peroxide results in increased degradation of [CCL5 protein binds to CCL5 protein]], Heparitin Sulfate inhibits the reaction [Hydrogen Peroxide results in increased degradation of CCL5 protein] CTD PMID:21963154 hesperetin multiple interactions ISO RGD:1604061 6480464 hesperetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] CTD PMID:24707119 hexadecanoic acid multiple interactions ISO RGD:1604061 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA CTD PMID:32613381 homocysteine multiple interactions ISO RGD:1604061 6480464 [Homocysteine co-treated with Lipopolysaccharides] results in increased secretion of CCL5 protein CTD PMID:16225753 homocysteine increases expression ISO RGD:1604061 6480464 Homocysteine results in increased expression of CCL5 mRNA CTD PMID:16225753 hyaluronic acid increases secretion ISO RGD:69127 6480464 Hyaluronic Acid analog results in increased secretion of CCL5 protein CTD PMID:9278343 hydrazines increases expression ISO RGD:69127 6480464 Hydrazines results in increased expression of CCL5 mRNA CTD PMID:21647536 hydrogen peroxide increases degradation ISO RGD:1604061 6480464 Hydrogen Peroxide results in increased degradation of CCL5 protein CTD PMID:21963154 hydrogen peroxide increases expression ISO RGD:1604061 6480464 Hydrogen Peroxide results in increased expression of CCL5 protein CTD PMID:18441283 hydrogen peroxide multiple interactions ISO RGD:1604061 6480464 [Copper co-treated with Hydrogen Peroxide] promotes the reaction [CCL5 protein binds to CCL5 protein] more ... CTD PMID:18441283 , PMID:21963154 hydroquinone increases expression ISO RGD:1604061 6480464 hydroquinone results in increased expression of CCL5 protein CTD PMID:17572062 hydroxytyrosol multiple interactions ISO RGD:1604061 6480464 [Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3, 4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA CTD PMID:16797527 indometacin affects expression EXP 6480464 Indomethacin affects the expression of CCL5 protein CTD PMID:25051504 ionomycin multiple interactions ISO RGD:1604061 6480464 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL5 protein more ... CTD PMID:17572062 , PMID:17685462 iron atom increases expression ISO RGD:1604061 6480464 Iron deficiency results in increased expression of CCL5 mRNA CTD PMID:20368581 iron(0) increases expression ISO RGD:1604061 6480464 Iron deficiency results in increased expression of CCL5 mRNA CTD PMID:20368581 isotretinoin multiple interactions ISO RGD:1604061 6480464 Isotretinoin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA], Isotretinoin inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] CTD PMID:15972972 isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of CCL5 mRNA CTD PMID:15972972 isotretinoin decreases expression ISO RGD:1604061 6480464 Isotretinoin results in decreased expression of CCL5 mRNA CTD PMID:15972972 itraconazole multiple interactions ISO RGD:1604061 6480464 Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] CTD PMID:23688403 kaempferol multiple interactions ISO RGD:1604061 6480464 [Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3, 4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA CTD PMID:16797527 ketamine multiple interactions ISO RGD:69127 6480464 [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 mRNA], [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein] CTD PMID:22245128 ketoconazole multiple interactions ISO RGD:1604061 6480464 Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]] more ... CTD PMID:16784723 , PMID:23688403 lanatoside C decreases expression ISO RGD:1604061 6480464 lanatoside C results in decreased expression of CCL5 protein CTD PMID:20116850 lead diacetate increases expression ISO RGD:69127 6480464 lead acetate results in increased expression of CCL5 mRNA CTD PMID:29746905 lead(0) multiple interactions ISO RGD:69127 6480464 Lead results in increased expression of and results in increased secretion of CCL5 protein CTD PMID:28973681 lead(2+) multiple interactions ISO RGD:69127 6480464 Lead results in increased expression of and results in increased secretion of CCL5 protein CTD PMID:28973681 lead(II) chloride increases secretion ISO RGD:1604061 6480464 lead chloride results in increased secretion of CCL5 protein CTD PMID:16099135 leukotriene B4 multiple interactions EXP 6480464 [Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4 more ... CTD PMID:18083043 lipopolysaccharide increases expression ISO RGD:1604061 6480464 Lipopolysaccharides results in increased expression of CCL5 mRNA, Lipopolysaccharides results in increased expression of CCL5 protein CTD PMID:15460210 more ... lipopolysaccharide increases secretion ISO RGD:69127 6480464 Lipopolysaccharides results in increased secretion of CCL5 protein CTD PMID:24561310 , PMID:32800949 lipopolysaccharide multiple interactions EXP 6480464 Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of CCL5 mRNA] CTD PMID:28693884 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CCL5 mRNA, Lipopolysaccharides results in increased expression of CCL5 protein CTD PMID:28693884 , PMID:33727093 lipopolysaccharide increases secretion ISO RGD:1604061 6480464 Lipopolysaccharides results in increased secretion of CCL5 protein CTD PMID:15289356 more ... lipopolysaccharide increases expression ISO RGD:69127 6480464 Lipopolysaccharides results in increased expression of CCL5 mRNA, Lipopolysaccharides results in increased expression of CCL5 protein CTD PMID:19133137 more ... lipopolysaccharide multiple interactions ISO RGD:1604061 6480464 1 more ... CTD PMID:15460210 more ... lipopolysaccharide multiple interactions ISO RGD:69127 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] more ... CTD PMID:15135318 more ... losartan multiple interactions EXP 6480464 Losartan inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] CTD PMID:16284884 Luliconazole multiple interactions ISO RGD:1604061 6480464 luliconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] CTD PMID:23688403 LY294002 multiple interactions ISO RGD:69127 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] CTD PMID:22225513 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of CCL5 mRNA CTD PMID:28801915 mangiferin multiple interactions ISO RGD:69127 6480464 mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein] CTD PMID:15135318 maraviroc multiple interactions ISO RGD:1604061 6480464 maraviroc inhibits the reaction [CCL5 protein binds to CCR5 protein] CTD PMID:15644495 masoprocol multiple interactions EXP 6480464 Masoprocol inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4] more ... CTD PMID:18083043 mechlorethamine increases expression EXP 6480464 Mechlorethamine results in increased expression of CCL5 mRNA CTD PMID:26273949 meclocycline decreases expression ISO RGD:1604061 6480464 meclocycline results in decreased expression of CCL5 protein CTD PMID:20116850 melatonin multiple interactions ISO RGD:69127 6480464 Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] CTD PMID:22225513 melatonin multiple interactions ISO RGD:1604061 6480464 Melatonin inhibits the reaction [cyfluthrin results in increased expression of CCL5 mRNA] CTD PMID:31330490 menadione multiple interactions EXP 6480464 Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL5 mRNA], Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of CCL5 protein] CTD PMID:19265712 menadione increases secretion EXP 6480464 Vitamin K 3 results in increased secretion of CCL5 protein CTD PMID:19265712 menadione increases expression EXP 6480464 Vitamin K 3 results in increased expression of CCL5 mRNA CTD PMID:19265712 mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of CCL5 mRNA CTD PMID:23358152 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of CCL5 mRNA, Mercuric Chloride results in increased expression of CCL5 protein CTD PMID:12834626 mercury dichloride increases response to substance EXP 6480464 CCL5 protein results in increased susceptibility to Mercuric Chloride CTD PMID:12834626 metam multiple interactions ISO RGD:69127 6480464 methyldithiocarbamate inhibits the reaction [Poly I-C results in increased secretion of CCL5 protein] CTD PMID:24056979 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of CCL5 mRNA CTD PMID:19564919 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CCL5 protein CTD PMID:25051504 methionine sulfoximine decreases expression ISO RGD:1604061 6480464 Methionine Sulfoximine results in decreased expression of CCL5 protein CTD PMID:20116850 methotrexate multiple interactions ISO RGD:1604061 6480464 SB 203580 promotes the reaction [Methotrexate results in increased expression of CCL5 protein] CTD PMID:19100307 methotrexate decreases expression ISO RGD:1604061 6480464 Methotrexate results in decreased expression of CCL5 mRNA CTD PMID:17400583 methotrexate increases expression ISO RGD:1604061 6480464 Methotrexate results in increased expression of CCL5 mRNA, Methotrexate results in increased expression of CCL5 protein CTD PMID:19100307 , PMID:21678067 Methylbenzethonium chloride decreases expression ISO RGD:1604061 6480464 methylbenzethonium chloride results in decreased expression of CCL5 protein CTD PMID:20116850 methylisothiazolinone increases secretion ISO RGD:1604061 6480464 2-methyl-4-isothiazolin-3-one results in increased secretion of CCL5 protein CTD PMID:30806763 methylmercury chloride increases expression ISO RGD:69127 6480464 methylmercuric chloride results in increased expression of CCL5 mRNA CTD PMID:24213012 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:30744511 methylmercury chloride increases expression ISO RGD:1604061 6480464 methylmercuric chloride results in increased expression of CCL5 mRNA CTD PMID:29581082 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of CCL5 protein CTD PMID:28526320 microcystin-LR multiple interactions EXP 6480464 [Dietary Fats co-treated with Cholesterol, Dietary co-treated with cyanoginosin LR] results in increased expression of CCL5 protein CTD PMID:34740672 minocycline decreases expression ISO RGD:1604061 6480464 Minocycline results in decreased expression of CCL5 protein CTD PMID:20116850 monocrotaline affects expression EXP 6480464 Monocrotaline affects the expression of CCL5 protein CTD PMID:25051504 monodansylcadaverine multiple interactions ISO RGD:69127 6480464 monodansylcadaverine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL5 protein] CTD PMID:22341560 morphine multiple interactions ISO RGD:1604061 6480464 beta-funaltrexamine inhibits the reaction [Morphine results in decreased expression of CCL5 protein], Naloxone inhibits the reaction [Morphine results in decreased expression of CCL5 protein] CTD PMID:11106302 morphine decreases expression ISO RGD:1604061 6480464 Morphine results in decreased expression of CCL5 protein CTD PMID:11106302 mycophenolic acid multiple interactions EXP 6480464 [Quercetin co-treated with Mycophenolic Acid] results in decreased expression of CCL5 mRNA CTD PMID:10688038 mycophenolic acid decreases expression EXP 6480464 Mycophenolic Acid results in decreased expression of CCL5 mRNA CTD PMID:10688038 N-acetyl-L-cysteine multiple interactions ISO RGD:69127 6480464 Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] CTD PMID:10495789 N-acetyl-L-cysteine multiple interactions ISO RGD:1604061 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of CCL5 protein] more ... CTD PMID:11167962 more ... N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CCL5 mRNA CTD PMID:28801915 N-methyl-N-nitrosourea increases expression ISO RGD:69127 6480464 Methylnitrosourea results in increased expression of CCL5 mRNA CTD PMID:15240709 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CCL5 protein CTD PMID:25051504 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CCL5 mRNA CTD PMID:20360939 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CCL5 protein CTD PMID:25051504 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CCL5 mRNA CTD PMID:25380136 naloxone multiple interactions ISO RGD:1604061 6480464 Naloxone inhibits the reaction [Morphine results in decreased expression of CCL5 protein] CTD PMID:11106302 naringin multiple interactions ISO RGD:1604061 6480464 naringin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CCL5 protein] CTD PMID:21500970 neocuproine multiple interactions ISO RGD:69127 6480464 neocuproine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL5 protein] CTD PMID:23604539 neoechinulin A increases expression ISO RGD:69127 6480464 neoechinulin A results in increased expression of CCL5 mRNA CTD PMID:19818335 nickel atom multiple interactions ISO RGD:69127 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA CTD PMID:23503329 nickel atom increases expression ISO RGD:1604061 6480464 Nickel results in increased expression of CCL5 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride increases secretion ISO RGD:1604061 6480464 nickel chloride results in increased secretion of CCL5 protein CTD PMID:18437699 nickel sulfate affects expression ISO RGD:1604061 6480464 nickel sulfate affects the expression of CCL5 mRNA CTD PMID:18202158 nickel sulfate increases secretion ISO RGD:1604061 6480464 nickel sulfate results in increased secretion of CCL5 protein CTD PMID:16099135 niclosamide multiple interactions ISO RGD:69127 6480464 Niclosamide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL5 protein] CTD PMID:24561310 nicotine increases expression ISO RGD:1604061 6480464 Nicotine results in increased expression of CCL5 mRNA CTD PMID:18247414 nitric oxide decreases secretion ISO RGD:1604061 6480464 Nitric Oxide results in decreased secretion of CCL5 protein CTD PMID:13678430 nitric oxide multiple interactions ISO RGD:69127 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide] more ... CTD PMID:19016906 nitrogen dioxide increases expression ISO RGD:1604061 6480464 Nitrogen Dioxide results in increased expression of CCL5 mRNA CTD PMID:27206323 o-anisidine increases expression ISO RGD:1604061 6480464 2-anisidine results in increased expression of CCL5 mRNA CTD PMID:28089782 ochratoxin A affects expression EXP 6480464 ochratoxin A affects the expression of CCL5 mRNA CTD PMID:32468156 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CCL5 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of CCL5 mRNA CTD PMID:25729387 oxytetracycline decreases expression ISO RGD:1604061 6480464 Oxytetracycline results in decreased expression of CCL5 protein CTD PMID:20116850 ozone decreases expression ISO RGD:69127 6480464 Ozone results in decreased expression of CCL5 mRNA CTD PMID:12763052 ozone multiple interactions ISO RGD:1604061 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of CCL5 mRNA CTD PMID:31476115 ozone increases expression ISO RGD:1604061 6480464 Ozone results in increased expression of CCL5 mRNA CTD PMID:31476115 ozone multiple interactions ISO RGD:69127 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CCL5 mRNA more ... CTD PMID:27472835 , PMID:34911549 palmatine decreases expression ISO RGD:1604061 6480464 palmatine results in decreased expression of CCL5 protein CTD PMID:20116850 paracetamol affects expression ISO RGD:69127 6480464 Acetaminophen affects the expression of CCL5 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1604061 6480464 Acetaminophen results in increased expression of CCL5 mRNA CTD PMID:29067470 paracetamol multiple interactions EXP 6480464 Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL5 mRNA], Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of CCL5 protein] CTD PMID:19265712 paracetamol increases expression ISO RGD:69127 6480464 Acetaminophen results in increased expression of CCL5 mRNA CTD PMID:15578514 parthenolide multiple interactions ISO RGD:69127 6480464 parthenolide inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA], parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA] CTD PMID:23958496 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23829299 PD123319 multiple interactions EXP 6480464 PD 123319 inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] CTD PMID:16284884 pentachlorophenol increases secretion ISO RGD:1604061 6480464 Pentachlorophenol results in increased secretion of CCL5 protein CTD PMID:35550411 pentanal increases expression ISO RGD:1604061 6480464 pentanal results in increased expression of CCL5 mRNA CTD PMID:26079696 Pentoxifylline decreases expression EXP 6480464 Pentoxifylline results in decreased expression of CCL5 mRNA CTD PMID:14993492 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of CCL5 mRNA CTD PMID:19162173 perfluorooctanoic acid increases expression ISO RGD:1604061 6480464 perfluorooctanoic acid results in increased expression of CCL5 mRNA CTD PMID:36326898 permethrin increases expression EXP 6480464 Permethrin results in increased expression of CCL5 protein CTD PMID:21616133 pevonedistat affects expression ISO RGD:1604061 6480464 pevonedistat affects the expression of CCL5 mRNA CTD PMID:24634471 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CCL5 mRNA CTD PMID:20360939 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CCL5 protein CTD PMID:25051504 phloretin multiple interactions ISO RGD:1604061 6480464 Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] CTD PMID:24707119 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1604061 6480464 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL5 protein more ... CTD PMID:17572062 , PMID:17685462 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:69127 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CCL5 mRNA CTD PMID:31904401 phytoestrogen decreases expression ISO RGD:69127 6480464 Phytoestrogens results in decreased expression of CCL5 protein CTD PMID:24388399 pioglitazone multiple interactions ISO RGD:69127 6480464 pioglitazone inhibits the reaction [Toluene 2, 4-Diisocyanate results in increased expression of CCL5 protein] CTD PMID:17015710 pioglitazone decreases response to substance ISO RGD:1604061 6480464 pioglitazone results in decreased susceptibility to CCL5 protein CTD PMID:18158351 pirinixic acid multiple interactions ISO RGD:69127 6480464 pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL5 mRNA], pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL5 protein] CTD PMID:15814532 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CCL5 mRNA CTD PMID:12832660 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CCL5 mRNA CTD PMID:19162173 pirinixic acid decreases expression ISO RGD:69127 6480464 pirinixic acid results in decreased expression of CCL5 mRNA CTD PMID:17426115 platycodin D multiple interactions ISO RGD:1604061 6480464 platycodin D inhibits the reaction [IL1B protein results in increased secretion of CCL5 protein] CTD PMID:27743553 poly(I:C) multiple interactions ISO RGD:1604061 6480464 15-deoxy-delta(12 more ... CTD PMID:23688403 , PMID:24709138 poly(I:C) increases expression ISO RGD:69127 6480464 Poly I-C results in increased expression of CCL5 mRNA CTD PMID:25780039 poly(I:C) increases secretion ISO RGD:69127 6480464 Poly I-C results in increased secretion of CCL5 protein CTD PMID:24056979 poly(I:C) multiple interactions ISO RGD:69127 6480464 APPL1 protein promotes the reaction [Poly I-C results in increased expression of CCL5 mRNA] more ... CTD PMID:24056979 , PMID:25780039 poly(I:C) increases expression ISO RGD:1604061 6480464 Poly I-C results in increased expression of CCL5, Poly I-C results in increased expression of CCL5 mRNA CTD PMID:23688403 , PMID:24709138 polymyxin B2 multiple interactions ISO RGD:69127 6480464 Polymyxin B inhibits the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL5 protein] CTD PMID:26882889 polymyxin B2 multiple interactions ISO RGD:1604061 6480464 Polymyxin B inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL5 protein] CTD PMID:29348435 prazosin multiple interactions ISO RGD:1604061 6480464 Prazosin inhibits the reaction [Norepinephrine results in increased secretion of CCL5 protein] CTD PMID:16782692 procyanidin B3 multiple interactions ISO RGD:69127 6480464 [procyanidin B3 co-treated with Eicosapentaenoic Acid] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] CTD PMID:22169119 progesterone multiple interactions ISO RGD:1604061 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of CCL5 mRNA, TGFB1 protein promotes the reaction [Progesterone results in increased expression of CCL5 mRNA] CTD PMID:17404688 , PMID:21768398 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of CCL5 mRNA, [Estradiol co-treated with Progesterone] results in decreased expression of CCL5 protein CTD PMID:21277368 progesterone increases expression ISO RGD:1604061 6480464 Progesterone results in increased expression of CCL5 mRNA CTD PMID:21768398 propanal increases expression ISO RGD:1604061 6480464 propionaldehyde results in increased expression of CCL5 mRNA CTD PMID:26079696 propidium decreases expression ISO RGD:1604061 6480464 Propidium results in decreased expression of CCL5 protein CTD PMID:20116850 Proscillaridin decreases expression ISO RGD:1604061 6480464 Proscillaridin results in decreased expression of CCL5 protein CTD PMID:20116850 prostaglandin E2 decreases expression ISO RGD:1604061 6480464 Dinoprostone results in decreased expression of CCL5 mRNA CTD PMID:16303787 prostaglandin E2 multiple interactions ISO RGD:1604061 6480464 Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]] more ... CTD PMID:16784723 prostaglandin E2 multiple interactions ISO RGD:69127 6480464 Dinoprostone inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] more ... CTD PMID:10495789 , PMID:17667525 purine-6-thiol decreases expression EXP 6480464 Mercaptopurine results in decreased expression of CCL5 mRNA CTD PMID:23358152 pyocyanine decreases expression ISO RGD:69127 6480464 Pyocyanine results in decreased expression of CCL5 mRNA, Pyocyanine results in decreased expression of CCL5 protein CTD PMID:31078726 pyrrolidine dithiocarbamate multiple interactions ISO RGD:69127 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA], pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] CTD PMID:10495789 , PMID:22225513 quartz increases expression ISO RGD:1604061 6480464 Quartz results in increased expression of CCL5 mRNA CTD PMID:27917503 quercetin increases expression ISO RGD:69127 6480464 Quercetin results in increased expression of CCL5 mRNA CTD PMID:16455785 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of CCL5 mRNA CTD PMID:10688038 quercetin multiple interactions ISO RGD:1604061 6480464 [Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3, 4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA CTD PMID:16797527 quercetin multiple interactions EXP 6480464 [Quercetin co-treated with Mycophenolic Acid] results in decreased expression of CCL5 mRNA, Quercetin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] CTD PMID:10688038 , PMID:14654164 quercetin 3-O-beta-D-glucofuranoside multiple interactions EXP 6480464 isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] CTD PMID:14654164 quercetin 3-O-beta-D-glucopyranoside multiple interactions EXP 6480464 isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] CTD PMID:14654164 raloxifene increases expression ISO RGD:1604061 6480464 Raloxifene Hydrochloride results in increased expression of CCL5 mRNA CTD PMID:12154049 raloxifene decreases expression ISO RGD:1604061 6480464 Raloxifene Hydrochloride results in decreased expression of CCL5 protein CTD PMID:16842799 reactive oxygen species multiple interactions ISO RGD:1604061 6480464 CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species], IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]] CTD PMID:12797483 reactive oxygen species multiple interactions ISO RGD:69127 6480464 1 more ... CTD PMID:10495789 , PMID:19016906 reactive oxygen species increases expression ISO RGD:69127 6480464 Reactive Oxygen Species results in increased expression of CCL5 mRNA CTD PMID:10495789 resveratrol multiple interactions ISO RGD:1604061 6480464 resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CCL5 protein], resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] CTD PMID:24707119 , PMID:24895526 resveratrol multiple interactions ISO RGD:69127 6480464 resveratrol inhibits the reaction [lipopolysaccharide more ... CTD PMID:24041027 resveratrol decreases expression ISO RGD:69127 6480464 resveratrol analog results in decreased expression of CCL5 mRNA, resveratrol results in decreased expression of CCL5 protein CTD PMID:15652768 more ... rifampicin decreases expression EXP 6480464 Rifampin results in decreased expression of CCL5 protein CTD PMID:25051504 rofecoxib increases expression ISO RGD:69127 6480464 rofecoxib results in increased expression of CCL5 mRNA, rofecoxib results in increased expression of CCL5 protein CTD PMID:17667525 rofecoxib multiple interactions ISO RGD:69127 6480464 Dinoprostone inhibits the reaction [rofecoxib results in increased expression of CCL5 mRNA], Dinoprostone inhibits the reaction [rofecoxib results in increased expression of CCL5 protein] CTD PMID:17667525 rutin multiple interactions EXP 6480464 Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of CCL5 mRNA] CTD PMID:28693884 rutin decreases expression EXP 6480464 Rutin results in decreased expression of CCL5 mRNA CTD PMID:28693884 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1604061 6480464 [S-(1 more ... CTD PMID:35811015 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:1604061 6480464 Buthionine Sulfoximine promotes the reaction [TNF protein results in increased expression of CCL5 protein], SB 203580 inhibits the reaction [Buthionine Sulfoximine promotes the reaction [TNF protein results in increased expression of CCL5 protein]] CTD PMID:11167962 S-nitrosoglutathione decreases secretion ISO RGD:1604061 6480464 S-Nitrosoglutathione results in decreased secretion of CCL5 protein CTD PMID:13678430 salubrinal multiple interactions ISO RGD:69127 6480464 salubrinal inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA], salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA] CTD PMID:23958496 SB 203580 multiple interactions ISO RGD:1604061 6480464 SB 203580 inhibits the reaction [[Toluene 2 more ... CTD PMID:10919993 more ... serpentine asbestos increases expression ISO RGD:69127 6480464 Asbestos, Serpentine results in increased expression of CCL5 protein CTD PMID:17200189 serpentine asbestos multiple interactions ISO RGD:69127 6480464 PRKDC affects the reaction [Asbestos, Serpentine results in increased expression of CCL5 protein] CTD PMID:17200189 silicon dioxide increases expression ISO RGD:1604061 6480464 Silicon Dioxide analog results in increased expression of CCL5 mRNA, Silicon Dioxide results in increased expression of CCL5 mRNA CTD PMID:23806026 more ... silicon dioxide increases secretion ISO RGD:1604061 6480464 Silicon Dioxide results in increased secretion of CCL5 protein CTD PMID:22300531 silicon dioxide increases expression ISO RGD:69127 6480464 Silicon Dioxide results in increased expression of CCL5 mRNA CTD PMID:23221170 , PMID:29341224 silicon dioxide multiple interactions ISO RGD:69127 6480464 [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein CTD PMID:22155353 silicon dioxide increases secretion ISO RGD:69127 6480464 Silicon Dioxide results in increased secretion of CCL5 protein CTD PMID:19073995 silver atom affects expression ISO RGD:69127 6480464 Silver affects the expression of CCL5 mRNA CTD PMID:27131904 silver(0) affects expression ISO RGD:69127 6480464 Silver affects the expression of CCL5 mRNA CTD PMID:27131904 simvastatin increases expression ISO RGD:1604061 6480464 Simvastatin results in increased expression of CCL5 mRNA CTD PMID:17183729 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of CCL5 protein CTD PMID:17449418 simvastatin decreases expression ISO RGD:1604061 6480464 Simvastatin results in decreased expression of CCL5 mRNA CTD PMID:17112859 sodium arsenite increases expression ISO RGD:1604061 6480464 sodium arsenite results in increased expression of CCL5 mRNA CTD PMID:28229933 sodium arsenite multiple interactions ISO RGD:69127 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL5 protein CTD PMID:35777461 sodium chloride increases expression EXP 6480464 Sodium Chloride results in increased expression of CCL5 protein CTD PMID:20232302 sodium cholate multiple interactions ISO RGD:69127 6480464 [eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of CCL5 mRNA CTD PMID:23665937 sodium dichromate decreases expression ISO RGD:69127 6480464 sodium bichromate results in decreased expression of CCL5 mRNA CTD PMID:22155349 sodium dichromate increases secretion ISO RGD:1604061 6480464 sodium bichromate results in increased secretion of CCL5 protein CTD PMID:17685462 sodium dichromate multiple interactions ISO RGD:1604061 6480464 sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL5 protein] CTD PMID:17685462 sodium dodecyl sulfate increases secretion ISO RGD:1604061 6480464 Sodium Dodecyl Sulfate results in increased secretion of CCL5 protein CTD PMID:16099135 sodium dodecyl sulfate increases expression ISO RGD:1604061 6480464 Sodium Dodecyl Sulfate results in increased expression of CCL5 mRNA CTD PMID:31734321 Sodium oleate multiple interactions ISO RGD:1604061 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA CTD PMID:32613381 Soman multiple interactions ISO RGD:69127 6480464 [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 mRNA], [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein] CTD PMID:22245128 Soman increases expression ISO RGD:69127 6480464 Soman results in increased expression of CCL5 mRNA, Soman results in increased expression of CCL5 protein CTD PMID:22245128 streptozocin increases expression ISO RGD:69127 6480464 Streptozocin results in increased expression of CCL5 mRNA CTD PMID:29420703 succimer multiple interactions ISO RGD:69127 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL5 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL5 mRNA CTD PMID:21641980 , PMID:26378955 succimer multiple interactions ISO RGD:1604061 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL5 mRNA CTD PMID:26378955 sulforaphane multiple interactions ISO RGD:69127 6480464 sulforaphane inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA], sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA] CTD PMID:23958496 sulindac multiple interactions ISO RGD:1604061 6480464 Sulindac inhibits the reaction [IL1B protein results in increased expression of CCL5 mRNA], Sulindac inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] CTD PMID:16159934 sunitinib decreases expression ISO RGD:69127 6480464 Sunitinib results in decreased expression of CCL5 mRNA CTD PMID:27560553 tacrine decreases expression EXP 6480464 Tacrine results in decreased expression of CCL5 mRNA CTD PMID:12832660 tacrolimus hydrate decreases expression ISO RGD:1604061 6480464 Tacrolimus results in decreased expression of CCL5 mRNA CTD PMID:15948978 tacrolimus hydrate multiple interactions ISO RGD:69127 6480464 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA] more ... CTD PMID:23958496 tacrolimus hydrate increases expression ISO RGD:69127 6480464 Tacrolimus results in increased expression of CCL5 mRNA CTD PMID:23958496 , PMID:25270620 tamibarotene increases expression ISO RGD:1604061 6480464 tamibarotene results in increased expression of CCL5 mRNA CTD PMID:15498508 tamibarotene decreases expression ISO RGD:69127 6480464 tamibarotene results in decreased expression of CCL5 mRNA CTD PMID:20861477 taurocholic acid increases expression ISO RGD:69127 6480464 Taurocholic Acid results in increased expression of CCL5 mRNA CTD PMID:21224055 telmisartan decreases response to substance ISO RGD:1604061 6480464 telmisartan results in decreased susceptibility to CCL5 protein CTD PMID:18158351 temozolomide increases expression ISO RGD:1604061 6480464 Temozolomide results in increased expression of CCL5 mRNA CTD PMID:31758290 terameprocol multiple interactions ISO RGD:69127 6480464 terameprocol inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to CCL5 promoter]] CTD PMID:21138578 terbinafine multiple interactions ISO RGD:1604061 6480464 Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]] more ... CTD PMID:16784723 , PMID:23688403 tert-butyl hydroperoxide increases expression ISO RGD:69127 6480464 tert-Butylhydroperoxide results in increased expression of CCL5 mRNA CTD PMID:14729362 , PMID:15003993 testosterone decreases expression ISO RGD:69127 6480464 Testosterone results in decreased expression of CCL5 mRNA CTD PMID:15788153 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL5 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO RGD:69127 6480464 Carbon Tetrachloride results in increased expression of CCL5 mRNA, Carbon Tetrachloride results in increased expression of CCL5 protein CTD PMID:17412915 , PMID:31919559 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of CCL5 mRNA CTD PMID:15963342 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CCL5 mRNA CTD PMID:16239168 , PMID:31150632 Tetramethylthiourea decreases expression ISO RGD:69127 6480464 tetramethylthiourea results in decreased expression of CCL5 mRNA CTD PMID:11128050 Tetramethylthiourea multiple interactions ISO RGD:69127 6480464 tetramethylthiourea inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA], tetramethylthiourea inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] CTD PMID:10495789 tetraphene multiple interactions ISO RGD:69127 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA CTD PMID:27858113 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of CCL5 protein CTD PMID:25051504 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CCL5 mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:1604061 6480464 titanium dioxide results in increased expression of CCL5 mRNA CTD PMID:19695317 titanium dioxide multiple interactions ISO RGD:1604061 6480464 [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of CCL5 protein CTD PMID:30711708 titanium dioxide decreases expression ISO RGD:69127 6480464 titanium dioxide results in decreased expression of CCL5 mRNA CTD PMID:27760801 titanium dioxide increases expression ISO RGD:69127 6480464 titanium dioxide results in increased expression of CCL5 mRNA, titanium dioxide results in increased expression of CCL5 protein CTD PMID:23557971 , PMID:28646487 titanium dioxide increases secretion ISO RGD:1604061 6480464 titanium dioxide results in increased secretion of CCL5 protein CTD PMID:20005940 tofacitinib multiple interactions ISO RGD:1604061 6480464 Cycloheximide inhibits the reaction [tofacitinib inhibits the reaction [TNF protein results in increased expression of CCL5 protein]] more ... CTD PMID:22121136 toluene 2,4-diisocyanate affects response to substance ISO RGD:1604061 6480464 CCL5 gene polymorphism affects the susceptibility to Toluene 2, 4-Diisocyanate CTD PMID:18447907 toluene 2,4-diisocyanate decreases expression ISO RGD:69127 6480464 Toluene 2, 4-Diisocyanate results in decreased expression of CCL5 mRNA CTD PMID:21404309 toluene 2,4-diisocyanate increases expression EXP 6480464 Toluene 2, 4-Diisocyanate results in increased expression of CCL5 mRNA CTD PMID:15823807 toluene 2,4-diisocyanate increases expression ISO RGD:69127 6480464 Toluene 2 more ... CTD PMID:11467998 more ... toluene 2,4-diisocyanate multiple interactions ISO RGD:69127 6480464 BAY 11-7085 inhibits the reaction [Toluene 2 more ... CTD PMID:12356572 more ... toluene 2,4-diisocyanate multiple interactions ISO RGD:1604061 6480464 [Toluene 2 more ... CTD PMID:16908450 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CCL5 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of CCL5 mRNA CTD PMID:25729387 trametinib multiple interactions ISO RGD:69127 6480464 trametinib promotes the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA], trametinib promotes the reaction [Poly I-C results in increased expression of CCL5 mRNA] CTD PMID:25780039 tremolite asbestos decreases expression ISO RGD:69127 6480464 tremolite results in decreased expression of CCL5 mRNA CTD PMID:29279043 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CCL5 mRNA, triadimefon results in increased expression of CCL5 protein CTD PMID:36179991 triamcinolone acetonide multiple interactions ISO RGD:1604061 6480464 Triamcinolone Acetonide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] CTD PMID:10903220 Tributyltin oxide decreases expression ISO RGD:69127 6480464 bis(tri-n-butyltin)oxide results in decreased expression of CCL5 mRNA CTD PMID:18958704 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CCL5 mRNA CTD PMID:20955722 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CCL5 mRNA CTD PMID:33387578 trichloroethene increases expression ISO RGD:69127 6480464 Trichloroethylene results in increased expression of CCL5 mRNA, Trichloroethylene results in increased expression of CCL5 protein CTD PMID:29669109 , PMID:33930529 troglitazone increases expression ISO RGD:1604061 6480464 troglitazone results in increased expression of CCL5 mRNA CTD PMID:19140230 tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate multiple interactions ISO RGD:69127 6480464 [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 mRNA], [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein] CTD PMID:22245128 urethane multiple interactions ISO RGD:69127 6480464 [Urethane co-treated with Freund's Adjuvant] results in increased expression of CCL5 mRNA CTD PMID:12400877 ursodeoxycholic acid multiple interactions ISO RGD:1604061 6480464 Ursodeoxycholic Acid analog inhibits the reaction [TNF protein promotes the reaction [Cycloheximide results in increased expression of CCL5 mRNA]] CTD PMID:21146893 ursodeoxycholic acid multiple interactions ISO RGD:69127 6480464 Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL5 mRNA], Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased secretion of CCL5 protein] CTD PMID:21146893 vanadyl sulfate increases expression ISO RGD:1604061 6480464 vanadyl sulfate results in increased expression of CCL5 protein CTD PMID:18684396 verteporfin multiple interactions ISO RGD:69127 6480464 Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL5 protein] CTD PMID:31812773 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CCL5 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CCL5 mRNA CTD PMID:23034163 vincristine increases expression ISO RGD:1604061 6480464 Vincristine results in increased expression of CCL5 mRNA CTD PMID:23649840 vitamin E multiple interactions ISO RGD:1604061 6480464 [Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3, 4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA CTD PMID:16797527 wortmannin multiple interactions ISO RGD:69127 6480464 wortmannin inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide], wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] CTD PMID:19016906 , PMID:22225513 WR-1065 increases expression ISO RGD:1604061 6480464 N-(2-mercaptoethyl)-1, 3-diaminopropane results in increased expression of CCL5 mRNA CTD PMID:12007958 zinc atom multiple interactions ISO RGD:69127 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA CTD PMID:23503329 zinc oxide affects expression EXP 6480464 Zinc Oxide affects the expression of CCL5 protein CTD PMID:33205376 zinc(0) multiple interactions ISO RGD:69127 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA CTD PMID:23503329
